반응 #471141
ord-e3eab900c1db45568cb555b2baf487b5
반응 방정식
반응물
시약
반응 조건
후처리
- 1기타before being partitioned between 2M aqueous hydrochloric acid and ethyl acetate
- 2세척The organic layer was washed with saturated aqueous sodium bicarbonate solution and brine
- 3건조before being dried over magnesium sulphate
- 4기타evaporated in vacuo
- 5workup.DISSOLUTIONThe residue was dissolved in 4M hydrogen chloride in dioxane
- 6workup.STIRRINGstirred for 7 hours at room temperature
- 7기타The reagent was removed in vacuo
- 8기타the residue partitioned between ethyl acetate and saturated aqueous sodium bicarbonate solution
- 9세척The separated organic fraction was washed with brine
- 10건조before being dried over magnesium sulphate
- 11기타evaporated in vacuo
- 12기타The crude material was purified by column chromatography (silica)
- 13세척eluting with methanol
실험 절차
A solution of (2R)-{[(2R)-2-[(tert-butoxycarbonyl)amino]-2-(2,3-dihydro-1H-inden-2-yl)ethanoyl][(1R)-1-(methoxycarbonyl)-3-methylbutyl]amino}(4-fluorophenyl)ethanoic acid (73 mg) in N,N-dimethylformamide (2 ml) was sequentially treated with diisopropylethylamine (51 μL), phosphorus, (1-hydroxy-1H-benzotriazolato-O)tri-1-pyrrolidinyl-(T-4)-hexafluorophosphate (80 mg) and then after 2 minutes, 2,2,2-trifluoroethylamine (25 μl). This reaction mixture was stirred for 2 hours before being partitioned between 2M aqueous hydrochloric acid and ethyl acetate. The organic layer was washed with saturated aqueous sodium bicarbonate solution and brine before being dried over magnesium sulphate and evaporated in vacuo. The residue was dissolved in 4M hydrogen chloride in dioxane and stirred for 7 hours at room temperature. The reagent was removed in vacuo and the residue partitioned between ethyl acetate and saturated aqueous sodium bicarbonate solution. The separated organic fraction was washed with brine before being dried over magnesium sulphate and evaporated in vacuo. The crude material was purified by column chromatography (silica) eluting with methanol: dichloromethane (1% to 3%) to furnish ((2R)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-2-(4-fluorophenyl)-N-(2,2,2-trifluoroethyl)ethanamide (10 mg)